more

Patterson Companies (PDCO)

(Delayed Data from NSDQ)

$23.22 USD

-0.56 (-2.35%)

Updated Jun 10, 2024 04:00 PM ET

After-Market: $23.22 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank	Definition	Annualized Return
1	Strong Buy	24.08%
2	Buy	17.91%
3	Hold	9.44%
4	Sell	5.10%
5	Strong Sell	2.55%
S&P	500	11.04%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5 4

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score	A
Growth Score	A
Momentum Score	A
VGM Score	A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value D Growth D Momentum C VGM

Industry Rank:

Bottom 29% (176 out of 248)

Industry: Medical - Dental Supplies

View All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Ciena (CIEN) to Report Q3 Earnings: What's in the Offing?

by Zacks Equity Research Published on September 01,2020

Ciena's (CIEN) fiscal third-quarter performance is likely to have benefited from the proper execution of its strategy that centers on innovation, diversification and global scale.

tech-stocks

What's in Store for Patterson Companies' (PDCO) Q1 Earnings?

by Zacks Equity Research Published on September 01,2020

Patterson Companies' (PDCO) fiscal first-quarter results are likely to reflect sluggishness at Dental segment.

Patterson Cos. (PDCO) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

by Zacks Equity Research Published on August 27,2020

Patterson Cos. (PDCO) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

PDCONegative Net Change

Medtronic's (MDT) Q1 Earnings Beat Estimates, Margins Fall

by Zacks Equity Research Published on August 25,2020

Barring Respiratory, Gastrointestinal & Renal, Medtronic (MDT) registers dismal performance in all business segments and geographies in Q1.

PDCO vs. CNMD: Which Stock Should Value Investors Buy Now?

by Zacks Equity Research Published on August 21,2020

PDCO vs. CNMD: Which Stock Is the Better Value Option?

5 PEG-Driven Value Stocks to Invest in Coronavirus-Hit Market

by Urmimala Biswas Published on August 17,2020

PEG ratio is complicated, considering the limitations in calculating the future earnings growth potential of a stock.

Is Patterson Cos. (PDCO) Stock Undervalued Right Now?

by Zacks Equity Research Published on August 12,2020

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

PDCONegative Net Change

Has Patterson Companies (PDCO) Outpaced Other Medical Stocks This Year?

by Zacks Equity Research Published on August 11,2020

Is (PDCO) Outperforming Other Medical Stocks This Year?

PDCONegative Net Change

PDCO vs. COO: Which Stock Should Value Investors Buy Now?

by Zacks Equity Research Published on August 05,2020

PDCO vs. COO: Which Stock Is the Better Value Option?

Patterson Cos. (PDCO) Hits 52-Week High, Can the Run Continue?

by Zacks Equity Research Published on August 05,2020

Patterson Cos. (PDCO) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Will Patterson Cos. (PDCO) Beat Estimates Again in Its Next Earnings Report?

by Zacks Equity Research Published on August 04,2020

Patterson Cos. (PDCO) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

PDCONegative Net Change

Boston Scientific (BSX) Q2 Earnings Top, Margins Decline

by Zacks Equity Research Published on July 29,2020

This time too Boston Scientific (BSX) refrains from providing any update on the full-year guidance.

Amedisys (AMED) Earnings and Revenues Beat Estimates in Q2

by Zacks Equity Research Published on July 29,2020

Amedisys' (AMED) second-quarter results reflect impressive performance by the Hospice division despite pandemic-led challenges.

Omnicell (OMCL) Q2 Earnings Lag Estimates, Margins Down

by Zacks Equity Research Published on July 29,2020

Omnicell's (OMCL) second-quarter revenues suffered due to slowdown in hospital purchasing decisions and product bookings owing to pandemic-led business disruptions.